A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir When Given With Raltegravir in Healthy Adult Volunteers.

Trial Profile

A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir When Given With Raltegravir in Healthy Adult Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs Danoprevir (Primary) ; Raltegravir; Ritonavir
  • Indications Hepatitis C; HIV infections; HIV-1 infections
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 20 Jan 2014 Actual end date changed from Aug 2012 to Mar 2012 as reported by ClinicalTrials.gov.
    • 19 Sep 2012 Actual end date changed from May 2012 to Aug 2012 as reported by ClinicalTrials.gov.
    • 01 May 2012 Actual end date (1 May 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top